Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 1999 Mar 1;189(5):753-6.
doi: 10.1084/jem.189.5.753.

CD4 T cells and their role in antitumor immune responses

R E Toes  1 , F Ossendorp, R Offringa, C J Melief
Affiliations
Comment

CD4 T cells and their role in antitumor immune responses

R E Toes et al. J Exp Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Halder T, Pawelec G, Kirkin AF, Zeuthen J, Meyer HE, Kun L, Kalbacher H. Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3. Cancer Res. 1997;57:3238–3244. - PubMed
    1. Topalian SL, Gonzales MI, Parkhurst M, Li YF, Southwood S, Sette A, Rosenberg SA, Robbins PF. Melanoma-specific CD4+T cells recognize nonmutated HLA-DR–restricted tyrosinase epitopes. J Exp Med. 1996;183:1965–1971. - PMC - PubMed
    1. Manici S, Sturniolo T, Imro MA, Hammer J, Sinigaglia F, Noppen C, Spagnoli G, Mazzi B, Bellone M, Dellabona P, Protti MP. Melanoma cells present a MAGE-3 epitope to CD4+cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J Exp Med. 1999;189:871–876. - PMC - PubMed
    1. Pieper R, Christian RE, Gonzales MI, Nishimura MI, Gupta G, Settlage RE, Shabanowitz J, Rosenberg SA, Hunt DF, Topalian SL. Biochemical identification of a mutated human melanoma antigen recognized by CD4+T cells. J Exp Med. 1999;189:757–765. - PMC - PubMed
    1. Chaux P, Vantomme V, Stroobant V, Thielemans K, Corthals J, Luiten R, Eggermont AMM, Boon T, van der Bruggen P. Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4+T lymphocytes. J Exp Med. 1999;189:767–777. - PMC - PubMed

Substances